|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
34
|
|
pubmed:dateCreated |
2006-11-30
|
|
pubmed:abstractText |
This multicenter, phase II study was conducted to evaluate the activity of amrubicin, a topoisomerase II inhibitor, against refractory or relapsed small-cell lung cancer (SCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:Asaka-AmanoYoshikoY,
pubmed-author:EguchiKenjiK,
pubmed-author:HaradaMasaoM,
pubmed-author:IsobeHiroshiH,
pubmed-author:KunikaneHiroshiH,
pubmed-author:KuriyamaTakayukiT,
pubmed-author:KuroiwaYumiY,
pubmed-author:MasudaNoriyukiN,
pubmed-author:OguraTakashiT,
pubmed-author:OkamotoHiroakiH,
pubmed-author:OnodaSayakaS,
pubmed-author:SekiNobuhikoN,
pubmed-author:SetoTakashiT,
pubmed-author:TagawaAkihiroA,
pubmed-author:TakiguchiYuichiY,
pubmed-author:Thoracic Oncology Research Group Study 0301,
pubmed-author:UematsuKazutsuguK,
pubmed-author:WatanabeKoshiroK,
pubmed-author:YokobaMasanoriM,
pubmed-author:YokoyamaAkiraA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5448-53
|
|
pubmed:meshHeading |
pubmed-meshheading:17135647-Aged,
pubmed-meshheading:17135647-Anthracyclines,
pubmed-meshheading:17135647-Antineoplastic Agents,
pubmed-meshheading:17135647-Carcinoma, Small Cell,
pubmed-meshheading:17135647-Drug Resistance, Neoplasm,
pubmed-meshheading:17135647-Female,
pubmed-meshheading:17135647-Hematologic Diseases,
pubmed-meshheading:17135647-Humans,
pubmed-meshheading:17135647-Infusions, Intravenous,
pubmed-meshheading:17135647-Lung Neoplasms,
pubmed-meshheading:17135647-Male,
pubmed-meshheading:17135647-Middle Aged,
pubmed-meshheading:17135647-Neoplasm Recurrence, Local,
pubmed-meshheading:17135647-Palliative Care,
pubmed-meshheading:17135647-Quality of Life,
pubmed-meshheading:17135647-Survival Rate,
pubmed-meshheading:17135647-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.
|
|
pubmed:affiliation |
Department of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Clinical Trial, Phase II
|
